Presentation is loading. Please wait.

Presentation is loading. Please wait.

Daniel Frenkel et al. JACEP 2016;2:

Published byAlbert Chapman Modified over 6 years ago

Similar presentations

Presentation on theme: "Daniel Frenkel et al. JACEP 2016;2:"— Presentation transcript:

1 Daniel Frenkel et al. JACEP 2016;2:295-303
Comparison of Rates of Left Atrial Thrombus and Spontaneous Echocontrast Detection by Transesophageal Echocardiography Among Patients on Direct Oral Anticoagulant Therapy Versus Warfarin Percentages of patients with transesophageal echocardiography findings are displayed. LAT = left atrial thrombus; NOAC = non-vitamin K antagonist oral anticoagulants; SEC = spontaneous echocardiographic contrast. See Online Videos 1 and 2. Daniel Frenkel et al. JACEP 2016;2: American College of Cardiology Foundation

Download ppt "Daniel Frenkel et al. JACEP 2016;2:"

Similar presentations

Subtherapeutic anticoagulation with dabigatran following Roux-en-Y gastric bypass surgery  Daniel Lee, MD, Zachariah DeFilipp, MD, Kenneth Judson, DO,

Subtherapeutic anticoagulation with dabigatran following Roux-en-Y gastric bypass surgery  Daniel Lee, MD, Zachariah DeFilipp, MD, Kenneth Judson, DO,
Muhammad Shahreyar et al. JACEP 2016;j.jacep

Muhammad Shahreyar et al. JACEP 2016;j.jacep
Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:
Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Lilian Mantziari et al. JACEP 2015;1:

Lilian Mantziari et al. JACEP 2015;1:
Tom F. Brouwer et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:
Marwan Badri et al. JACEP 2015;1:

Marwan Badri et al. JACEP 2015;1:
Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.
Adil Rajwani et al. JACEP 2015;1:

Adil Rajwani et al. JACEP 2015;1:
Waddah Maskoun et al. JACEP 2016;2:

Waddah Maskoun et al. JACEP 2016;2:
Konstantinos C. Siontis et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:
FAERS death cases (all years) for NOACs versus warfarin.

FAERS death cases (all years) for NOACs versus warfarin.
Shadi Al Halabi et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:
Niyada Naksuk et al. JACEP 2016;2:

Niyada Naksuk et al. JACEP 2016;2:
Lilian Mantziari et al. JACEP 2015;1:

Lilian Mantziari et al. JACEP 2015;1:
Kenshi Hayashi et al. JACEP 2016;2:

Kenshi Hayashi et al. JACEP 2016;2:
Ashish Shukla et al. JACEP 2015;1:41-51

Ashish Shukla et al. JACEP 2015;1:41-51
S.M. Afzal Sohaib et al. JACEP 2015;1:

S.M. Afzal Sohaib et al. JACEP 2015;1:
Alexander Sedaghat et al. JACEP 2017;3:71-75

Alexander Sedaghat et al. JACEP 2017;3:71-75

Similar presentations

Ads by Google